GL
Gland Pharma
GLAND.NS·NSEHyderabad INFounded 19786,000 employees
Mid CappharmaPublicOncology
Platform: Injectable Gen
Market Cap
$4B
All Drugs
3
Clinical Trials
5
Failed / Terminated
2
FDA Approved
0
Stock Price & Catalysts (GLAND.NS)
Loading GLAND.NS stock data...
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Tixatuximab | GLA-4817 | Phase 3 | 2 | CD123 | EoEHNSCC | ||
| Polazasiran | GLA-2470 | Preclinical | 2 | TNFα | Prostate Ca | ||
| GLA-2545 | GLA-2545 | Phase 2 | 1 | WEE1 | FLSLE |
SEC Filings & Financial Documents
SEC filings are not available for NSE-listed companies.
Gland Pharma trades on NSE (IN). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (4)